文献速递产科母胎医学

美国妊娠队列中碘摄入不足与过量的患病率

Prevalence of inadequate and excessive iodine intake in a US pregnancy cohort.
PubMed 文献 · Am J Obstet Gynecol · 2020-07-09

该前瞻性妊娠队列于2008至2015年纳入464名孕妇、共1014份尿标本,按孕早期、孕中期、孕晚期分别估算尿碘中位数并与世界卫生组织150 μg/L切点比较,同时估算碘摄入不足与过量的患病率,结果为23%与<1%。

要点

  • 孕早期、孕中期、孕晚期尿碘中位数分别为171 μg/L、181 μg/L、179 μg/L,各孕期无显著差异(P=.50)。
  • 估算的碘摄入不足患病率为23%,碘摄入过量患病率为<1%。
  • 美国甲状腺协会、内分泌学会和美国儿科学会推荐所有孕妇和哺乳期妇女每日补充含150 μg碘的复合维生素或矿物质补充剂。

核心结论

  • 各孕期尿碘中位数均高于世界卫生组织150 μg/L切点,提示群体水平碘充足;但估算的碘摄入不足患病率达23%,而碘摄入过量患病率<1%,提示至少部分孕妇需要增加碘摄入。
  • 作者认为本文数据应鼓励采集更多美国人群样本的类似数据,以为美国妇产科医师学会制定产前碘补充的潜在推荐提供依据。

研究设计与样本

  • 前瞻性妊娠队列研究,2008至2015年于首次产前门诊就诊时入组,排除标准少(<18岁或非英语使用者),样本未针对任何特定健康状况筛选。
  • 共纳入464名妇女的1014份尿标本(每人1至6份),孕期常规产检时尽量每个孕期至少采集1份,-80°C保存后测定尿碘。
  • 按孕周和孕期分析尿碘,使用每人多份尿标本并校正个体内变异,经数据转换近似正态后估算碘摄入不足与过量的患病率。

主要发现

  • 孕妇特征:53%为非西班牙裔白人、22%为非西班牙裔黑人、16%为西班牙裔;48%受教育程度为高中及以下;71%年收入<$25,000。
  • 孕早期尿碘中位数为171 μg/L(n=305份标本),孕中期为181 μg/L(n=366份标本),孕晚期为179 μg/L(n=343份标本),各孕期无显著差异(P=.50,Kruskal-Wallis检验中位数相等性)。
  • 估算的碘摄入不足患病率为23%,碘摄入过量患病率为<1%。

关键数值与推荐

  • 世界卫生组织切点为尿碘中位数150 μg/L,本文各孕期尿碘中位数均高于该切点。
  • 美国甲状腺协会、内分泌学会和美国儿科学会推荐所有孕妇和哺乳期妇女每日接受含150 μg碘的复合维生素或矿物质补充剂。

临床怎么用

  • 美国甲状腺协会、内分泌学会和美国儿科学会推荐所有孕妇和哺乳期妇女每日接受含150 μg碘的复合维生素或矿物质补充剂。
  • 作者认为本文数据应鼓励采集更多美国人群样本的类似数据,以为美国妇产科医师学会制定产前碘补充的潜在推荐提供依据。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: US iodine intake, estimated from the median urinary iodine concentration of population representative data, has declined by half since the 1970s, which is problematic because maternal iodine intake is critical for fetal neurodevelopment. Relying on median urinary concentrations to assess iodine intake of populations is standard practice but does not describe the number of individuals with insufficient intake. Prevalence estimates of inadequate and excessive intake are better for informing public health applications but require multiple urine samples per person; such estimates have been generated in pediatric populations but not yet among pregnant women. OBJECTIVE: Our aims were as follows: (1) to assess median urinary iodine concentrations across pregnancy for comparison with national data and (2) to estimate the prevalence of inadequate and excessive iodine intake among pregnant women in mid-Michigan. STUDY DESIGN: Data were collected from 2008 to 2015 as part of a prospective pregnancy cohort in which women were enrolled at their first prenatal clinic visit. Few exclusion criteria (<18 years or non-English speaking) resulted in a sample of women generally representative of the local community, unselected for any specific health conditions. Urine specimens were obtained as close as practicable to at least 1 specimen per trimester during routine prenatal care throughout pregnancy (n=1-6 specimens per woman) and stored at -80°C until urinary iodine was measured to estimate the iodine intake (n=1014 specimens from 464 women). We assessed urinary iodine across pregnancy by each gestational week of pregnancy and by trimester. We used multiple urine specimens per woman, accounted for within-person variability, performed data transformation to approximate normality, and estimated the prevalence of inadequate and excessive iodine intake using a method commonly employed for assessment of nutrient status. RESULTS: Maternal characteristics reflected the local population in racial and ethnic diversity and socioeconomic status as follows: 53% non-Hispanic white, 22% non-Hispanic black, and 16% Hispanic; 48% had less than or equal to high school education and 71% had an annual income of <$25,000. Median urinary iodine concentrations in the first, second, and third trimester-including some women contributing more than 1 specimen per trimester-were 171 μg/L (n=305 specimens), 181 μg/L (n=366 specimens), and 179 μg/L (n=343 specimens), respectively, with no significant difference by trimester (P=.50, Kruskal-Wallis test for equality of medians). The estimated prevalence of inadequate and excessive iodine intake was 23% and <1%, respectively. CONCLUSION: Median urinary iodine concentrations in each trimester were above the World Health Organization cutoff of 150 μg/L, indicating iodine sufficiency at the group level across pregnancy. However, the estimated prevalence of inadequate iodine intake was substantial at 23%, whereas prevalence of excessive intake was <1%, indicating a need for at least some women to increase consumption of iodine during pregnancy. The American Thyroid Association, the Endocrine Society, and the American Academy of Pediatrics recommend that all pregnant and lactating women receive a daily multivitamin or mineral supplement that contains 150 μg of iodine. The data presented here should encourage the collection of similar data from additional US population samples for the purpose of informing the American College of Obstetricians and Gynecologists' own potential recommendations for prenatal iodine supplementation.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kerver JM, Pearce EN, Ma T, et al. Prevalence of inadequate and excessive iodine intake in a US pregnancy cohort. Am J Obstet Gynecol. 2020. PMID: 32653458. doi:10.1016/j.ajog.2020.06.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。